Postpartum-derived cells for use in treatment of disease of the heart and circulatory system
US8703121B2 · kind B2 · utility
26Cited by
82References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 25, 2004 |
| Grant date | Apr 22, 2014 |
| Priority date | — |
| Expiry date | May 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2533/50
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cells derived from postpartum tissue and methods for their use in treatment of diseases of the heart or circulatory system are disclosed. Cells may be used in either differentiated or undifferentiated forms, in homogenous cultures, or as populations with other cells, and in conjunction with other bioactive factors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.